本页面由Tiger Trade Technology Pte. Ltd.提供服务

MBX Biosciences

49.00
-3.0200-5.81%
盘后:48.77-0.2300-0.47%19:30 EDT
成交量:76.90万
成交额:3,846.32万
市值:23.60亿
市盈率:-20.37
高:53.04
开:52.04
低:48.91
收:52.02
52周最高:72.64
52周最低:12.94
股本:4,816.01万
流通股本:2,762.99万
量比:1.44
换手率:2.78%
股息:- -
股息率:- -
每股收益(TTM):-2.4052
每股收益(LYR):-2.3824
净资产收益率:-33.17%
总资产收益率:-22.08%
市净率:5.76
市盈率(LYR):-20.57

数据加载中...

2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/05

重要事件披露

Form 8-K - Current report
2026/01/22

重要事件披露

Form 8-K - Current report
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities